These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12403298)

  • 1. Studies on the influence of auxiliary substances on the physico-chemical characteristics of ophthalmic drugs. Part I. Studies on the influence of auxiliary substances on the critical micellar concentration of surfactants solutions in eye drops containing sulphacetamidum natricum.
    Pluta J; Meler J
    Acta Pol Pharm; 2002; 59(4):247-52. PubMed ID: 12403298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micellar solutions of triblock copolymer surfactants with pilocarpine.
    Pepić I; Jalsenjak N; Jalsenjak I
    Int J Pharm; 2004 Mar; 272(1-2):57-64. PubMed ID: 15019069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of surfactants suitable for stabilizing of latanoprost.
    Ochiai A; Ohkuma M; Danjo K
    Int J Pharm; 2012 Oct; 436(1-2):732-7. PubMed ID: 22842310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the physico-chemical properties of ophthalmic viscolysers on the weight of drops dispensed from a flexible dropper bottle.
    Van Santvliet L; Ludwig A
    Eur J Pharm Sci; 1999 Mar; 7(4):339-45. PubMed ID: 9971918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the force effect of aqueous and oily eye drops.
    Müller F; Wagner M; Neubert RH
    Pharmazie; 2005 Apr; 60(4):283-7. PubMed ID: 15881609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions.
    Rao VM; Lin M; Larive CK; Southard MZ
    J Pharm Sci; 1997 Oct; 86(10):1132-7. PubMed ID: 9344170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of penetration enhancers on the volume instilled of eye drops.
    Van Santvliet L; Ludwig A
    Eur J Pharm Biopharm; 1998 Mar; 45(2):189-98. PubMed ID: 9704916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of Carbopol 940 ophthalmic vehicles, and in vitro evaluation of the influence of simulated lacrimal fluid on their physico-chemical properties.
    Unlü N; Ludwig A; van Ooteghem M; Hincal AA
    Pharmazie; 1991 Nov; 46(11):784-8. PubMed ID: 1811229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between epithelial toxicity and surfactant structure as derived from the effects of polyethyleneoxide surfactants on caco-2 cell monolayers and pig nasal mucosa.
    Ekelund K; Osth K; Påhlstorp C; Björk E; Ulvenlund S; Johansson F
    J Pharm Sci; 2005 Apr; 94(4):730-44. PubMed ID: 15682384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimicrobial agents in eyedrops].
    Sklubalová Z
    Ceska Slov Farm; 2004 May; 53(3):107-16. PubMed ID: 15218731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method for the obtaining of increased viscosity eye drops containing amikacin.
    Sikora A; Oszczapowicz I; Tejchman B; Grzechnik M
    Acta Pol Pharm; 2005; 62(1):31-7. PubMed ID: 16022491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation studies on sulphacetamide eye-drops. Part 2: Spectrophotometric evaluation of decomposition products of UV-irradiated solutions of sulphacetamide.
    Ahmad T
    Pharmazie; 1982 Aug; 37(8):559-61. PubMed ID: 7146062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reverse phase ion-pairing HPLC method for the stability monitoring of sulphacetamide ophthalmic preparations.
    Rao RM; Rao YM; Shah AH
    J Pharm Biomed Anal; 1999 Aug; 20(4):717-22. PubMed ID: 10704141
    [No Abstract]   [Full Text] [Related]  

  • 14. Surfactant solutions and porous substrates: spreading and imbibition.
    Starov VM
    Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of selected polymers on the surface tension of solutions developed for the preparation of eye drops.
    Gasztych M; Burdzy K; Dołowacka-Jóźwiak A; Musiał W
    Polim Med; 2023; 53(2):111-116. PubMed ID: 38054367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ophthalmic suspensions using surface tension.
    Yasueda S; Inada K; Matsuhisa K; Terayama H; Ohtori A
    Eur J Pharm Biopharm; 2004 Mar; 57(2):377-82. PubMed ID: 15018999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physical and chemical stability of fortified ophtalmic ready-to-use solutions: review of literature].
    Sourdeau P; Evrard JM; Remy G; Hecq JD
    Ann Pharm Fr; 2012 Mar; 70(2):104-12. PubMed ID: 22500962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technology of eye drops containing aloe (Aloe arborescens Mill.--Liliaceae) and eye drops containing both aloe and neomycin sulphate.
    Kodym A; Marcinkowski A; Kukuła H
    Acta Pol Pharm; 2003; 60(1):31-9. PubMed ID: 12848365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorption kinetics in micellar solutions of nonionic surfactants.
    Colegate DM; Bain CD
    Phys Rev Lett; 2005 Nov; 95(19):198302. PubMed ID: 16384032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical modeling of pH-surfactant-mediated solubilization of nimesulide.
    Grbic S; Parojcic J; Djuric Z; Ibric S
    Drug Dev Ind Pharm; 2009 Jul; 35(7):852-6. PubMed ID: 19347760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.